Medable Appoints Ching Tian to Lead Strategy and Solutions Division to Further Advance Its Leadership Position in Digital Trials
Summary
In October, the Company announced an ex-Covance veteran, Alison Holland, joined the team to lead its Virtual Trials division. Over the past fifteen years, Ching has spearheaded a number of innovation projects through close collaboration with technology companies, transforming the processes at scale. She brings a vision for the future that is powered by experience, need, and transformation, further solidifying our leadership position in the digital trial space.” “I’m thrilled to join Medable at such a pivotal time for the company and the life sciences industry. I’m looking forward to working with the team to deliver faster, better, digital trials,” said Ching Tian as SVP, Strategy and Solutions, Medable. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution.